ICO Winter Meeting & Annual Montgomery Lecture 2021-virtual

10 December 2021

The ICO Winter Meeting and Annual Montgomery Lecture (virtual) will take place on Friday, 10th December.

Download Programme

ICO Winter Meeting

3pm Welcome
Prof Colm O'Brien, Chair ICO Scientific & Continuing Professional Development Committee
  Paper Presentations
3.02pm The role of αvΒ3 integrin and its inhibition in lamina cribrosa cell mechanotransduction in glaucoma
Sarah Powell
3.10pm Outcomes of genetic screening of an Irish paediatric inherited retinal degeneration population
Julia Zhu
3.18pm Validating circulating mirna biomarkers for AMD in an Irish population
Ian Brennan
3.26pm An evaluation of the safety and effectiveness of telephone triage in prioritising patient visits to an ophthalmic emergency department – the impact of COVID-19
Glynis Hanrahan
3.34pm Redefining Alport’s Syndrome: ocular phenotypes in type IV collagen disorder
Liam Tomas Mulcahy
3.42pm Candida blood stream infection: to screen or not to screen?
Amy O'Regan
3.50pm The efficacy of retinal pneumopexy in releasing vitreomacular traction
Matthew O'Riordan
3.58pm 6 Year retrospective study of the trends of anti-vascular growth factor therapy in retinal disease in University Hospital limerick
Eabha O'Driscoll
4.06pm Repeated corneal collagen – crosslinking (cXl) In Keratoconus in long-term outcome
Tayseer Mohamed
4.14pm Management of traumatic canalicular lacerations: comparison of bicanalicular silicone tube and monocanalicular mini-monoka repair at Cork University Hospital
Edward Ahern
4.22pm Ophthalmology input and ocular findings in patients with facial bone fractures in St Vincent’s University Hospital: January 2020 – November 2021
Michael Troy
4.30pm Posters (automated virtual slides presentation)
5.00pm Break
5.15pm Welcome & Introduction of the Annual Montgomery Lecture 2021
Mr Tim Fulcher, President, ICO
5.20pm Annual Montgomery Lecture 2021
"Developing a clinical research program - 30 years of Acanthamoeba keratitis

Prof John Dart has been researching Acanthamoeba keratitis disease for 30 years.  Although it is a relatively rare disease most ophthalmologists will have seen a case and know how severe it is.  Prof Dart began his research on the condition in the mid 1980’s when cases first started to increase and in his lecture, will discuss what he, and others, have done to answer the questions about the causes, environmental factors, development of diagnostic techniques and development of treatments from then to the preliminary results of their current treatment trial.
The focus will be on how a clinical research programme developed as a response to a new disease and an insight into what can be achieved.

Prof John KG Dart MA DM FRCOphth
Hon. Consultant Ophthalmologist, Hon. Professor, University College London, Moorfields Eye Hospital, London

John Dart has been a Consultant Ophthalmologist at Moorfields Eye Hospital since 1987 and an Honorary Professor of UCL, at the Institute of Ophthalmology since 2011, providing a tertiary referral service for patients with Corneal and External diseases until 2020 when he retired from clinical work. He has continued with his research focused principally on microbial keratitis and cicatrising conjunctivitis. His current studies, including a Phase II/III randomized trial of a new formulation of PHMB for the treatment of Acanthamoeba keratitis, are aimed at providing the first licensed therapy for this disease, and the development of topical ALDH inhibition to control the unmet need of scarring in cicatrising conjunctivitis. He has over 220 peer-reviewed publications, has trained 38 Corneal and External disease Fellows and 8 PhD/MD students; four of these now hold Chairs in Ophthalmology or Optometry. He has given 19 eponymous lectures including the EuCornea Medal 2015, the Bowman Medal (RCOphth) 2016 and the Castroviejo Medal (Corneal Society) 2019.

6.00pm Q&A
6.30pm Meeting Close